BRPI0807768A2 - Nova sialidase. - Google Patents

Nova sialidase.

Info

Publication number
BRPI0807768A2
BRPI0807768A2 BRPI0807768-1A2A BRPI0807768A BRPI0807768A2 BR PI0807768 A2 BRPI0807768 A2 BR PI0807768A2 BR PI0807768 A BRPI0807768 A BR PI0807768A BR PI0807768 A2 BRPI0807768 A2 BR PI0807768A2
Authority
BR
Brazil
Prior art keywords
sialidase
new
new sialidase
Prior art date
Application number
BRPI0807768-1A2A
Other languages
English (en)
Inventor
Albertus Alard Van Dijk
Petrus Jacobus Theodorus Dekker
Yulia M Efimova
Original Assignee
Dsm Ip Assests Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assests Bv filed Critical Dsm Ip Assests Bv
Publication of BRPI0807768A2 publication Critical patent/BRPI0807768A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0328—Enzymes other than milk clotting enzymes, e.g. lipase, beta-galactosidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
BRPI0807768-1A2A 2007-02-20 2008-02-18 Nova sialidase. BRPI0807768A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07102688 2007-02-20
PCT/EP2008/051930 WO2008101893A2 (en) 2007-02-20 2008-02-18 Novel sialidase

Publications (1)

Publication Number Publication Date
BRPI0807768A2 true BRPI0807768A2 (pt) 2014-06-24

Family

ID=39561900

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807768-1A2A BRPI0807768A2 (pt) 2007-02-20 2008-02-18 Nova sialidase.

Country Status (12)

Country Link
US (1) US8012733B2 (pt)
EP (1) EP2113027B1 (pt)
JP (1) JP5436225B2 (pt)
CN (1) CN101636489B (pt)
AU (1) AU2008219305B2 (pt)
BR (1) BRPI0807768A2 (pt)
CA (1) CA2676686C (pt)
ES (1) ES2492469T3 (pt)
HK (1) HK1138617A1 (pt)
NZ (1) NZ578882A (pt)
PL (1) PL2113027T3 (pt)
WO (1) WO2008101893A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ581390A (en) * 2007-06-25 2012-09-28 Dsm Ip Assets Bv Prebiotics comprising an oligosaccharide, sialyloligosaccharide and free sialic acid
US20120301576A1 (en) 2010-02-03 2012-11-29 Dsm Ip Assets B.V. Use of sialidase in dairy technology
EP2900259B1 (en) 2012-09-28 2020-04-15 Kline, Ellis Glycosidase regimen for treatment of infectious disease
JP6566869B2 (ja) * 2012-12-24 2019-08-28 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ 短時間作用性第ｖｉｉ因子ポリペプチド
CA2896899A1 (en) 2013-01-18 2014-07-24 Ellis KLINE Selective glycosidase regimen for immune programming and treatment of cancer
CN104004727B (zh) * 2014-06-09 2016-02-17 东北师范大学 一种具有唾液酸水解酶活性的蛋白质的制备方法
CN104004728B (zh) * 2014-06-09 2016-09-28 东北师范大学 一种具有唾液酸水解酶活性的蛋白质及其应用
CN104004801B (zh) * 2014-06-09 2016-06-29 东北师范大学 一种制备单唾液酸四己糖神经节苷脂的方法
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN112135904A (zh) 2018-01-03 2020-12-25 帕利昂制药有限公司 重组人唾液酸酶、唾液酸酶融合蛋白及其使用方法
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
CN115287371B (zh) * 2022-02-15 2023-12-01 中国食品药品检定研究院 一种检测产黄青霉菌基因组dna的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59501572A (ja) 1982-05-19 1984-09-06 ユニリーバー　ナームローゼ　ベンノートシヤープ クルイベロミセス属酵母およびその製造法
DE3480411D1 (en) 1983-07-06 1989-12-14 Gist Brocades Nv Molecular cloning and expression in industrial microorganism species
US4885249A (en) 1984-12-05 1989-12-05 Allelix, Inc. Aspergillus niger transformation system
ATE253119T1 (de) 1985-04-15 2003-11-15 Dsm Ip Assets Bv Verwendung des glucoamylasepromotors aus apergillus
NO872932L (no) 1986-07-18 1988-01-19 Gist Brocades Nv Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika.
EP0301670B2 (en) 1987-07-28 2000-06-14 Gist-Brocades N.V. Kluyveromyces as a host strain
EP0349666B1 (de) * 1988-07-07 1992-12-23 Milupa Aktiengesellschaft Verfahren zur enzymatischen Herstellung von bifidogener Säuglings- und Diätnahrung
DE69435304D1 (de) * 1993-05-17 2010-09-02 Genentech Inc Rekombinante CHO Zell Sialidase
EP0979294B1 (en) 1997-04-11 2015-05-27 DSM IP Assets B.V. Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
WO1999032617A2 (en) 1997-12-22 1999-07-01 Dsm N.V. Expression cloning in filamentous fungi
NZ528190A (en) 2001-03-21 2005-06-24 Dsm Ip Assets B Cheese making process
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
EP1904844A2 (en) * 2005-05-25 2008-04-02 The Johns-Hopkins University Compositions and methods for enhancing axon regeneration
NZ581390A (en) * 2007-06-25 2012-09-28 Dsm Ip Assets Bv Prebiotics comprising an oligosaccharide, sialyloligosaccharide and free sialic acid

Also Published As

Publication number Publication date
CN101636489A (zh) 2010-01-27
EP2113027A2 (en) 2009-11-04
CA2676686A1 (en) 2008-08-28
CA2676686C (en) 2015-12-15
US20100167344A1 (en) 2010-07-01
NZ578882A (en) 2012-01-12
HK1138617A1 (en) 2010-08-27
ES2492469T3 (es) 2014-09-09
AU2008219305A1 (en) 2008-08-28
JP5436225B2 (ja) 2014-03-05
EP2113027B1 (en) 2014-06-18
JP2010520746A (ja) 2010-06-17
US8012733B2 (en) 2011-09-06
AU2008219305B2 (en) 2013-08-22
CN101636489B (zh) 2014-08-13
WO2008101893A3 (en) 2009-01-08
PL2113027T3 (pl) 2014-11-28
WO2008101893A2 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
BRPI0807768A2 (pt) Nova sialidase.
NO2021006I1 (no) Quofenix, delafloksacin
BRPI0813235A2 (pt) Combinação anti-helmíntica.
ATE513831T1 (de) Pyridinä3,4-büpyrazinone
FR2909857B1 (fr) Endovalve.
BRPI0815717A2 (pt) Compostos de imidazopirazina.
CL2007002783S1 (es) Inhalador multidosis.
BRPI0814736A2 (pt) inalador.
BRPI0720224A2 (pt) Arilpirazóis substituídos
CL2008000689S1 (es) Protesis mamaria.
BRPI0907448A2 (pt) Instrumentos.
CL2008000919S1 (es) Grifo.
IT1396642B1 (it) Statore.
FR2915500B1 (fr) Garde-corps.
CL2008000920S1 (es) Grifo.
NL1033185C1 (nl) Tank.
ITCE20060002A1 (it) Patok.
FI20075945A0 (fi) Lohkokahmari
NL1033607A1 (nl) Bouwwerk.
CL2007003537S1 (es) Protesis mamaria.
ITPA20070017A1 (it) Ciottola.
FR2914939B1 (fr) Arret de vantail.
ES1065423Y (es) Conjunto chaleco-mochila.
NL1036071C (nl) Zelfperforerende ordner.
FR2935319B1 (fr) Fourgonnette amenagee.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]